Department of Paediatrics

Corrigendum to "Learnings from a registry-based cohort study for spinal muscular atrophy disease" [Neuromuscular Disorders, Volume 59, February 2026, 106332].

Jonker CJ. et al, (2026), Neuromuscul Disord

Immunisation of children and adolescents against COVID-19: immunogenicity and reactogenicity of heterologous and fractional dose schedules

Kelly E., (2026)

Disease-Attenuated Pneumococcal Biosynthesis Gene Mutants Invade the Mucosal Epithelium and Induce Innate Immunity.

Weight CM. et al, (2026), J Infect Dis

Recent Advances, Bottlenecks, and Future Directions in Plasmodium falciparum Vaccine Development.

Turan G. et al, (2026), Vaccines (Basel), 14

Exploring the ethics of tuberculosis human challenge models.

Rohrig A. et al, (2026), J Med Ethics, 52, 251 - 260

Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trials.

Bijukchhe SM. et al, (2026), Lancet Infect Dis

Human-specific features of the cerebellum and ZP2-regulated synapse development.

Kim S-K. et al, (2026), Cell, 189, 1802 - 1819.e28

Design, validation, and functional impact of oligonucleotides for multigene silencing in Alzheimer's disease.

Woffindale C. et al, (2026), Mol Ther Nucleic Acids, 37

Predicting how perturbations reshape cellular trajectories with PerturbGen

Chi Hao Ly K. et al, (2026)

Report of a one-day convening on regulatory science, practices, and innovative approaches to facilitate approval of novel combination vaccines.

Hausdorff WP. et al, (2026), Vaccine, 75

13-valent pneumococcal conjugate vaccine-induced B cells produce serotype 6B but not serotype 3 capsule-specific IgG antibodies in young Malawian adults.

Tembo G. et al, (2026), Vaccine, 75

Machine learning-driven identification of serotype-independent pneumococcal vaccine candidates using samples from human infection challenge studies.

Cheliotis KS. et al, (2026), Vaccine, 75

Crossing the finish line towards a disease-modifying treatment for Angelman syndrome.

Judson MC. et al, (2026), J Neurodev Disord, 18

Enhanced muscle uptake of chemically optimized miR-23b antisense oligonucleotides as lead compounds for myotonic dystrophy type 1.

González-Martínez I. et al, (2026), Am J Hum Genet, 113, 529 - 547

Targeted BDNF upregulation via upstream open reading frame disruption.

Feng N. et al, (2026), Mol Ther, 34, 1652 - 1671

Dosing practices of caffeine therapy for apnoea of prematurity: a retrospective single-centre observational study.

Fatunla OAT. et al, (2026), BMJ Paediatr Open, 10

Advances in Alphavirus and Flavivirus Research II.

Kim YC. and Reyes-Sandoval A., (2026), Viruses, 18

Structure-guided design of a PfCyRPA-based vaccine against blood-stage malaria.

Alam N. et al, (2026), EMBO Mol Med, 18, 873 - 890

The Epidemiology and Clinical Burden of Human Adenovirus Respiratory Infections Among Hospitalized Children Under 5 Years in Jordan.

Abu-Helalah M. et al, (2026), Pediatr Infect Dis J, 45, 229 - 235

Reshaping study design for faster extrapolation-based drug approval in pediatric inflammatory bowel diseases: An ESPGHAN-NASPGHAN position paper.

Turner D. et al, (2026), J Pediatr Gastroenterol Nutr, 82, 867 - 894

Search results

Showing results for